WELG:XETRA:XETRA-Amundi S&P Global Health Care ESG UCITS ETF DR EUR Inc (EUR)

ETF | Others |

Last Closing

USD 11.064

Change

+0.00 (+0.04)%

Market Cap

N/A

Volume

3.11K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.34 (-0.66%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.11 (-0.66%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.24 (-0.88%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.27 (-0.95%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.09 (-0.36%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

-1.08 (-0.76%)

USD 102.09B
JARI:XETRA Amundi Index Solutions - Amund..

-0.66 (-1.44%)

USD 101.20B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.33 (-0.65%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.24 (-0.23%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-1.62 (-0.27%)

USD 80.38B

ETFs Containing WELG:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.18% 41% F 46% F
Dividend Return 0.98% 11% F 13% F
Total Return 7.16% 43% F 47% F
Trailing 12 Months  
Capital Gain 6.69% 43% F 47% F
Dividend Return 0.98% 11% F 13% F
Total Return 7.67% 44% F 48% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.17% 50% F 51% F
Dividend Return 6.23% 49% F 49% F
Total Return 0.05% 10% F 6% D-
Risk Return Profile  
Volatility (Standard Deviation) 7.09% 77% C+ 82% B
Risk Adjusted Return 87.79% 80% B- 83% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.